Summary
Aflac Inc. reported mixed financial results for the second quarter and first half of 2014. While net earnings and diluted earnings per share saw a decline compared to the same periods in 2013, primarily due to the weakening Japanese Yen and lower realized investment gains, the company's underlying insurance operations showed resilience. Aflac Japan, which constitutes the majority of the company's business, experienced a decline in yen-denominated revenues and pretax operating earnings, influenced by unfavorable foreign currency translation effects. However, the company highlighted an increase in third sector product sales (cancer and medical) and a stable benefit ratio, signaling continued demand for these essential offerings. In the U.S., Aflac U.S. reported stable premium income and a slight increase in pretax operating earnings, driven by lower incurred claims and an improved expense ratio. The company also continued its share repurchase program, repurchasing $515 million of common stock in the first half of 2014.
Financial Highlights
32 data points| Revenue | $5.84B |
| SG&A Expenses | $537.00M |
| Operating Income | $1.16B |
| Interest Expense | $81.00M |
| Net Income | $810.00M |
| EPS (Basic) | $0.90 |
| EPS (Diluted) | $0.89 |
| Shares Outstanding (Basic) | 905.12M |
| Shares Outstanding (Diluted) | 910.76M |
Key Highlights
- 1Net earnings decreased to $810 million for Q2 2014 and $1.54 billion for the first six months of 2014, compared to $889 million and $1.78 billion in the prior year periods, respectively.
- 2Diluted EPS fell to $1.78 in Q2 2014 and $3.38 for the first six months, down from $1.90 and $3.80, respectively.
- 3Aflac Japan's pretax operating earnings declined by 1.3% in Q2 and 3.6% in the first six months (in USD terms), impacted by a weaker Japanese Yen.
- 4Aflac U.S. saw a 5.7% increase in pretax operating earnings for Q2 and 6.8% for the first six months, indicating improved operational performance.
- 5The company repurchased $515 million of common stock in the first six months of 2014 under its share repurchase program.
- 6Shareholders' equity benefited from a significant increase in net unrealized gains on investment securities and derivatives, rising to $2.9 billion from $1.0 billion at the end of 2013.